3rd Quarter - Report
BGR GOVERNMENT AFFAIRS for GILEAD SCIENCES, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOYER | See prior filing |
| JOSHUA SCOTT LAMEL New | Leg Counsel Sen. Wyden |
| RYAN LONG | See prior filing |
| JENNIFER LARKIN LUKAWSKI | See prior filing |
| JONATHAN MANTZ | See prior filing |
| LOREN MONROE | See prior filing |
| ROBERT WOOD | See prior filing |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.